EKF Diagnostics Holdings Plc (EKF) - Medical Equipment - Deals and Alliances Profile

EKF Diagnostics Holdings Plc (EKF) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME211150D
  • |
  • Pages: 48
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes point-of-care (POC) devices and tests and chemical reagents used for manufacturing in central laboratories. Its POC range includes hemoglobin analyzers, glucose analyzers and HbA1c analyzers that can be used for screening, monitoring and diagnosing patients, and conducting tests for common infectious diseases and pregnancy, while its Central Laboratory range includes various clinical reagents and centrifuges. Its products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. EKF Diagnostics offers its products across the world through its subsidiaries and distributors. The company operates manufacturing facilities in Russia, Poland, Germany, the UK, Ireland, and the US. EKF Diagnostics is headquartered in Cardiff, Wales, the UK.

EKF Diagnostics Holdings Plc (EKF)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note : Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

EKF Diagnostics Holdings Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

EKF Diagnostics Holdings Plc, Medical Equipment, Deal Details 12

Venture Financing 12

Selah Genomics Raises USD0.4 Million in Financing Round 12

Private Equity 13

Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 13

Partnerships 14

Icahn School of Medicine Enters into Licensing Agreement with EKF Diagnostics 14

EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 15

Arcis Biotech Enters Into Licensing Agreement With EKF Diagnostics 16

EKF Diagnostics Enters into Distribution Agreement with Asahi Kasei Pharma 17

Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 18

Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 19

EKF Diagnostics Enters into Co-Development Agreement with Angle 20

EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 21

Selah Genomics Enters Into Licensing Agreement With UNIConnect For UniFlow 22

Equity Offering 23

EKF Diagnostics Raises USD7 Million in Private Placement of Shares 23

Asset Transactions 25

EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 25

Acquisition 26

EKF Diagnostics Sells Selah Genomics 26

Jin Jing to Acquire EKF Diagnostics 27

EKF Diagnostics Completes Acquisition Of Selah Genomics For USD 75 Million 28

EKF Diagnostics To Acquire DiaSpect Medical For USD 34.4 Million 29

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For USD 4 Million 30

EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To USD 14.4 Million 31

Selah Genomics Acquires EnGenCore, DNA Sequencing Company 33

EKF Diagnostics Acquires 3.62% Stake In Arcis Biotech For USD 0.4 Million 34

EKF Diagnostics Sells International Brand Licensing For USD 0.08 Million 35

EKF Diagnostics Holdings Plc-Key Competitors 36

EKF Diagnostics Holdings Plc-Key Employees 37

EKF Diagnostics Holdings Plc-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 40

Financial Announcements 40

Mar 14, 2018: EKF Diagnostics Holdings: 2017 Final results 40

Sep 11, 2017: EKF Diagnostics Holdings: Half Yearly Report 44

Mar 20, 2017: EKF Diagnostics Holdings: Final results 45

Government and Public Interest 46

Jul 04, 2018: EKF Diagnostics: Exploring funding options for Renalytix AI business 46

Other Significant Developments 47

Jul 17, 2017: EKF publish new diabetes and HbA1c testing guide 47

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Figures

EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

EKF Diagnostics Holdings Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

EKF Diagnostics Holdings Plc, Medical Equipment, Key Facts, 2017 2

EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

EKF Diagnostics Holdings Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

EKF Diagnostics Holdings Plc, Deals By Market, 2012 to YTD 2018 9

EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Selah Genomics Raises USD0.4 Million in Financing Round 12

Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 13

Icahn School of Medicine Enters into Licensing Agreement with EKF Diagnostics 14

EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 15

Arcis Biotech Enters Into Licensing Agreement With EKF Diagnostics 16

EKF Diagnostics Enters into Distribution Agreement with Asahi Kasei Pharma 17

Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 18

Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 19

EKF Diagnostics Enters into Co-Development Agreement with Angle 20

EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 21

Selah Genomics Enters Into Licensing Agreement With UNIConnect For UniFlow 22

EKF Diagnostics Raises USD7 Million in Private Placement of Shares 23

EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 25

EKF Diagnostics Sells Selah Genomics 26

Jin Jing to Acquire EKF Diagnostics 27

EKF Diagnostics Completes Acquisition Of Selah Genomics For USD 75 Million 28

EKF Diagnostics To Acquire DiaSpect Medical For USD 34.4 Million 29

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For USD 4 Million 30

EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To USD 14.4 Million 31

Selah Genomics Acquires EnGenCore, DNA Sequencing Company 33

EKF Diagnostics Acquires 3.62% Stake In Arcis Biotech For USD 0.4 Million 34

EKF Diagnostics Sells International Brand Licensing For USD 0.08 Million 35

EKF Diagnostics Holdings Plc, Key Competitors 36

EKF Diagnostics Holdings Plc, Key Employees 37

EKF Diagnostics Holdings Plc, Other Locations 38

EKF Diagnostics Holdings Plc, Subsidiaries 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

EKF Diagnostics Holdings Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 18130
Site License
USD 500 INR 36260
Corporate User License
USD 750 INR 54390

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com